Novo Nordisk A/S vs United Airlines Holdings, Inc.: Strategic Comparison
Key Differences at a Glance
| Field | Novo Nordisk A/S | United Airlines Holdings, Inc. |
|---|---|---|
| Revenue | $46.0B | $59.1B |
| Founded | 1989 | 1926 |
| Employees | 69,505 | 113,200 |
| Market Cap | $550.0B | $38.2B |
| Headquarters | Denmark | United States |
Quick Stats Comparison
| Metric | Novo Nordisk A/S | United Airlines Holdings, Inc. |
|---|---|---|
| Revenue | $46.0B | $59.1B |
| Founded | 1989 | 1926 |
| Headquarters | Bagsvaerd, Denmark | Chicago, Illinois |
| Market Cap | $550.0B | $38.2B |
| Employees | 69,505 | 113,200 |
Novo Nordisk A/S Revenue vs United Airlines Holdings, Inc. Revenue — Year by Year
| Year | Novo Nordisk A/S | United Airlines Holdings, Inc. | Leader |
|---|---|---|---|
| 2025 | $46.0B | $59.1B | United Airlines Holdings, Inc. |
| 2024 | $42.7B | $57.1B | United Airlines Holdings, Inc. |
| 2023 | $34.0B | $53.7B | United Airlines Holdings, Inc. |
Business Model Breakdown
Overview: Novo Nordisk A/S vs United Airlines Holdings, Inc.
This in-depth comparison examines Novo Nordisk A/S and United Airlines Holdings, Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Novo Nordisk A/S on its own, evaluating United Airlines Holdings, Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Novo Nordisk A/S and United Airlines Holdings, Inc. is widest.
On the headline numbers, Novo Nordisk A/S reports annual revenue of $46.0B against $59.1B for United Airlines Holdings, Inc., while their respective market capitalizations stand at $550.0B and $38.2B. Novo Nordisk A/S is headquartered in Denmark and United Airlines Holdings, Inc. operates from United States, and those different home markets shape how each company competes.
Novo Nordisk A/S: Novo Nordisk A/S is a public company listed on NYSE under ticker NVO. Novo Nordisk makes money by developing and selling prescription medicines for diabetes, obesity, rare blood disorders, rare endocrine disorders, and related chronic diseases.
United Airlines Holdings, Inc.: A network airline is a coordination machine. United's value comes from putting the right aircraft, crew, schedules, airport slots, loyalty incentives, and corporate contracts together so thousands of connecting markets become sellable every day.
Business Models: How Novo Nordisk A/S and United Airlines Holdings, Inc. Make Money
Novo Nordisk A/S and United Airlines Holdings, Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Novo Nordisk A/S and United Airlines Holdings, Inc..
Novo Nordisk A/S business model: Novo Nordisk makes money by developing and selling prescription medicines for diabetes, obesity, rare blood disorders, rare endocrine disorders, and related chronic diseases.
United Airlines Holdings, Inc. business model: United makes money from passenger tickets, premium cabins, basic economy, cargo, MileagePlus loyalty economics, co-branded credit card revenue, baggage and seat fees, United Club memberships, and partner revenue. Hubs create network density that lets the airline fill aircraft and price global itineraries.
Competitive Advantage: Novo Nordisk A/S vs United Airlines Holdings, Inc.
The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Novo Nordisk A/S stack up against those of United Airlines Holdings, Inc..
Novo Nordisk A/S competitive advantage: Novo Nordisk's advantage is deep GLP-1 science, diabetes and obesity scale, global manufacturing, payer experience, and one of the world's strongest chronic-care franchises.
United Airlines Holdings, Inc. competitive advantage: United's advantage is its hub network, international route breadth, Star Alliance connectivity, premium-cabin expansion, MileagePlus loyalty base, corporate account strength, and major positions at airports such as Chicago O'Hare, Newark, Denver, Houston, San Francisco, Washington Dulles, and Los Angeles.
Growth Strategy: Where Novo Nordisk A/S and United Airlines Holdings, Inc. Are Headed
Future prospects matter as much as current results. The growth strategies below explain how Novo Nordisk A/S and United Airlines Holdings, Inc. each plan to expand from here.
Novo Nordisk A/S growth strategy: Novo Nordisk A/S's growth strategy centers on this advantage: Novo Nordisk's advantage is deep GLP-1 science, diabetes and obesity scale, global manufacturing, payer experience, and one of the world's strongest chronic-care franchises.
United Airlines Holdings, Inc. growth strategy: United is investing in premium seating, larger aircraft, international routes, operational reliability, MileagePlus, airport clubs, digital service, Starlink connectivity, and network depth at core hubs.
Financial Picture: Novo Nordisk A/S vs United Airlines Holdings, Inc.
A closer look at the financial trajectory of Novo Nordisk A/S and United Airlines Holdings, Inc. rounds out the comparison.
Novo Nordisk A/S: Novo Nordisk A/S reported FY2025 revenue of DKK 309.064B (about $46.0B) and net income of DKK 102.434B (about $15.2B).
United Airlines Holdings, Inc.: United's 2025 total operating revenue was USD 59.1 billion, up 3.5%. Operating income was USD 4.7 billion. Passenger revenue rose 3.1% as passengers increased 4.3% and capacity increased 6.1%, while other operating revenue grew 10.4% helped by loyalty and club revenue.
Company-Specific SWOT Notes
Novo Nordisk A/S
Novo Nordisk has global scale, clinical depth, and manufacturing experience in diabetes and obesity GLP-1 medicines.
A large share of investor expectations depends on continued Ozempic and Wegovy growth.
Obesity care, cardiovascular outcomes, oral formulations, and broader metabolic indications can expand the addressable market.
Rival incretin drugs, compounding, payer restrictions, safety scrutiny, and supply constraints can pressure growth.
United Airlines Holdings, Inc.
United's advantage is its hub network, international route breadth, Star Alliance connectivity, premium-cabin expansion, MileagePlus loyalty base, corporate account strength, and major positions at airports such as Chicago O'Hare, Newark, Denver, Houston, San Francisco, Washington Dulles, and Los Angeles.
United wins when its hubs, international routes, loyalty program, and premium seats make it the most convenient and valuable airline for high-frequency travelers.
The biggest risk is cost pressure from fuel, labor, aircraft delays, or disruption that outpaces fare and loyalty revenue growth.
United is investing in premium seating, larger aircraft, international routes, operational reliability, MileagePlus, airport clubs, digital service, Starlink connectivity, and network depth at core hubs.
Head-to-Head Scorecard
| Category | Winner | Why |
|---|---|---|
| Revenue Scale | United Airlines Holdings, Inc. | United Airlines Holdings, Inc. reports the larger revenue base ($59.1B), which serves as a core operational scale signal. |
| Profitability Potential | Comparable | Both organizations prioritize market penetration or are at equivalent reporting tiers. |
| Company Age | United Airlines Holdings, Inc. | Founded in 1989 vs 1926. The earlier pioneer typically commands longer historical institutional legacy. |
| Innovation Moat | Novo Nordisk A/S | Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity. |
| Scale (Employees) | United Airlines Holdings, Inc. | A significantly larger reported workforce supports enhanced global distribution capability. |
| Market Cap | Novo Nordisk A/S | Higher public valuation denotes greater forward-looking investor conviction in earnings potential. |
| Future Outlook | Tied | Strategic auditing assesses that both maintain defensive leadership vectors within their core market clusters. |
Who Wins Each Category?
United Airlines Holdings, Inc. reports the larger revenue base ($59.1B), which serves as a core operational scale signal.
Both organizations prioritize market penetration or are at equivalent reporting tiers.
Founded in 1989 vs 1926. The earlier pioneer typically commands longer historical institutional legacy.
Higher aggregate count of major acquisitions and key R&D releases indicates a more active technology absorption velocity.
A significantly larger reported workforce supports enhanced global distribution capability.
Who Wins: Novo Nordisk A/S or United Airlines Holdings, Inc.?
Reviewed by Swet Parvadiya, May 2026 - Author Profile
Our analysts compile business strategy profiles from public financial filings, press releases, and analyst reports. Each profile is reviewed for accuracy before publication by our editorial desk and updated on a rolling basis.
Frequently Asked Questions: Novo Nordisk A/S vs United Airlines Holdings, Inc.
Is Novo Nordisk A/S better than United Airlines Holdings, Inc.?
Verdict: Between Novo Nordisk A/S and United Airlines Holdings, Inc., United Airlines Holdings, Inc. is the stronger overall option based on higher annual revenue. The decision still depends on which factors matter most for your needs, but on the weight of the evidence above, United Airlines Holdings, Inc. comes out ahead in this Novo Nordisk A/S vs United Airlines Holdings, Inc. comparison.
Who earns more — Novo Nordisk A/S or United Airlines Holdings, Inc.?
United Airlines Holdings, Inc. earns more with $59.1B in annual revenue versus Novo Nordisk A/S's $46.0B. United Airlines Holdings, Inc. leads on total revenue based on latest verified figures.
Which company has higher revenue — Novo Nordisk A/S or United Airlines Holdings, Inc.?
Novo Nordisk A/S reported $46.0B, while United Airlines Holdings, Inc. reported $59.1B. The revenue leader is United Airlines Holdings, Inc. based on latest verified figures.
Novo Nordisk A/S revenue vs United Airlines Holdings, Inc. revenue — which is higher?
Novo Nordisk A/S revenue: $46.0B. United Airlines Holdings, Inc. revenue: $46.0B. United Airlines Holdings, Inc. has the larger revenue base of the two companies.
Sources & References
- Novo Nordisk A/S Corporate Website
- Novo Nordisk A/S Annual Report 2025 - Revenue and Financial Data
- sec.gov
- novonordisk.com
- SEC EDGAR: United Airlines Holdings, Inc. Annual Filings (10-K, 8-K)
- United Airlines Holdings, Inc. Corporate Website
- United Airlines Holdings, Inc. Annual Report 2025 - Revenue and Financial Data
- sec.gov
- united.com
- ir.united.com